Lung cancer pill, Osimertinib, shows 'earth-shattering' results in 5-year study
Osimertinib, sold under the brand name Tagrisso, is available to patients with Stage 1B-3A lung cancer who have a certain genetic mutation and have had surgery to removeĀ cancerous tumors.